Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Ligand Binding Sites02:40

Ligand Binding Sites

15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

91
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
91
Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

69
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
69
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

344
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
344

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a novel missense mutation c.655G>A in the A4GALT*02 allele from a Chinese individual with p phenotype.

Transfusion·2026
Same author

Incidence of endometrial cancer among postmenopausal women using vaginal estrogen compared to estrogen and progestin combination hormone therapy.

Menopause (New York, N.Y.)·2026
Same author

Consistency of response to rimegepant for the acute treatment of migraine among real-world users - findings from the prospective observational CONFIDENCE study.

The journal of headache and pain·2026
Same author

Martensitic Transformation and Strengthening Mechanism in a 304 Stainless Steel Subjected to Wire Drawing.

Materials (Basel, Switzerland)·2026
Same author

A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

Cephalalgia : an international journal of headache·2026
Same author

Fipexide (FPX), a chemical callus inducer, promotes in vitro shoot regeneration and <i>Agrobacterium</i>-mediated genetic transformation in three fruit tree species.

Plant biotechnology (Tokyo, Japan)·2026

Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

4.0K

Drug-target interaction prediction: databases, web servers and computational models.

Xing Chen, Chenggang Clarence Yan, Xiaotian Zhang

    Briefings in Bioinformatics
    |August 19, 2015
    PubMed
    Summary

    Computational models accelerate drug discovery by predicting drug-target interactions, overcoming experimental limitations. This review covers databases, web servers, and advanced methods like network-based and machine learning approaches for identifying potential drug-target associations.

    Keywords:
    biological networkscomputational modelsdrug discoverydrug–target interactions predictionmachine learning

    More Related Videos

    A Protocol for Computer-Based Protein Structure and Function Prediction
    16:41

    A Protocol for Computer-Based Protein Structure and Function Prediction

    Published on: November 3, 2011

    70.1K
    Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
    05:08

    Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

    Published on: July 8, 2025

    1.3K

    Related Experiment Videos

    Last Updated: Apr 5, 2026

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    4.0K
    A Protocol for Computer-Based Protein Structure and Function Prediction
    16:41

    A Protocol for Computer-Based Protein Structure and Function Prediction

    Published on: November 3, 2011

    70.1K
    Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
    05:08

    Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

    Published on: July 8, 2025

    1.3K

    Area of Science:

    • Computational biology
    • Drug discovery
    • Bioinformatics

    Background:

    • Experimental drug-target interaction identification is costly and time-consuming.
    • Computational models offer scalable solutions for predicting drug-target associations.
    • Databases and web servers are crucial resources in this field.

    Purpose of the Study:

    • To review existing databases and web servers for drug-target identification.
    • To introduce state-of-the-art computational models for predicting drug-target interactions.
    • To discuss future directions and advanced evaluation frameworks.

    Main Methods:

    • Summary of databases and web servers.
    • Introduction to network-based computational models.
    • Detailed explanation of machine learning-based models (supervised and semi-supervised).

    Main Results:

    • Significant improvements in drug-target interaction prediction using computational models.
    • Identification of limitations in current network-based and machine learning methods.
    • Discussion of novel evaluation frameworks and regression formulations.

    Conclusions:

    • Computational approaches are vital for efficient drug discovery.
    • Future research should focus on personalized drug discovery and improved validation.
    • Advanced methods offer promise for more accurate drug-target interaction prediction.